Action - PIP

Pharmathene, (delisted) (PIP) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

0,65

( - )

Prix Achat

Prix Vente

Volume échangé

0,00

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

0,65

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

PharmAthene Reports First Quarter 2017 Financial and Operational Results

PharmAthene Reports First Quarter 2017 Financial and Operational Results PR Newswire ANNAPOLIS, Md., May 3, 2017 ANNAPOLIS, Md., May 3, 2017...

PharmAthene Reports Year-End 2016 Financial and Operational Results

PharmAthene Reports Year-End 2016 Financial and Operational Results PR Newswire ANNAPOLIS, Md., March 14, 2017 ANNAPOLIS, Md., March 14, 2017...

PharmAthene Announces Record Date and Meeting Date for Special Meeting of Stockholders Regarding Proposed Merger Transaction ...

PharmAthene Announces Record Date and Meeting Date for Special Meeting of Stockholders Regarding Proposed Merger Transaction with Altimmune PR...

PPMH Wholly-Owned Subsidiary, mPath Discovery LLC, Expands Client Base with Multiple New Channel Partnership Agreements

MEMPHIS, Tennessee, February 8, 2017 - InvestorsHub NewsWire -- Platinum Pari-Mutuel Holdings (PPMH), a company focused on innovation and...

Altimmune to Present at the BIO CEO & Investor Conference

Altimmune to Present at the BIO CEO & Investor Conference PR Newswire GAITHERSBURG, Md., Feb. 6, 2017 GAITHERSBURG, Md., Feb. 6, 2017...

PharmAthene and Altimmune Announce Merger to Create Immunotherapeutics Company Targeting Infectious Diseases

PharmAthene and Altimmune Announce Merger to Create Immunotherapeutics Company Targeting Infectious Diseases PR Newswire ANNAPOLIS, Md. and...

PharmAthene Declares $2.91 Special Cash Dividend on Common Stock

PharmAthene Declares $2.91 Special Cash Dividend on Common Stock Final Payment of $83.9 Million Received from SIGA of $217 Million Total...

PharmAthene Receives Final Payment from SIGA of $83.9 Million

PharmAthene Receives Final Payment from SIGA of $83.9 Million - Award amount totals $217 million - PR Newswire ANNAPOLIS, Md., Nov. 16, 2016...

PharmAthene Reports Third Quarter 2016 Financial and Operational Results

PharmAthene Reports Third Quarter 2016 Financial and Operational Results PR Newswire ANNAPOLIS, Md., Nov. 4, 2016 ANNAPOLIS, Md., Nov. 4, 2016...

PharmAthene Announces Receipt of Payments from SIGA

PharmAthene Announces Receipt of Payments from SIGA PR Newswire ANNAPOLIS, Md., Sept. 16, 2016 ANNAPOLIS, Md., Sept. 16, 2016 /PRNewswire/...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

PIP - Frequently Asked Questions (FAQ)

What is the current Pharmathene, (delisted) share price?

The current share price of Pharmathene, (delisted) is US$ 0,65

What is the 1 year trading range for Pharmathene, (delisted) share price?

Pharmathene, (delisted) has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Pharmathene, (delisted) (PIP)

Pharmathene, (delisted) (PIP) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

PIP Dernières nouvelles

PharmAthene Reports First Quarter 2017 Financial and Operational Results

PharmAthene Reports Year-End 2016 Financial and Operational Results

PharmAthene Announces Record Date and Meeting Date for Special Meeting of Stockholders Regarding Proposed Merger Transaction ...

PPMH Wholly-Owned Subsidiary, mPath Discovery LLC, Expands Client Base with Multiple New Channel Partnership Agreements

Altimmune to Present at the BIO CEO & Investor Conference

PharmAthene and Altimmune Announce Merger to Create Immunotherapeutics Company Targeting Infectious Diseases

PharmAthene Declares $2.91 Special Cash Dividend on Common Stock

PharmAthene Receives Final Payment from SIGA of $83.9 Million

PharmAthene Reports Third Quarter 2016 Financial and Operational Results

PharmAthene Announces Receipt of Payments from SIGA

PIP - Frequently Asked Questions (FAQ)

PIP Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Pharmathene, (delisted) (PIP)

Pharmathene, (delisted) (PIP) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

PIP Dernières nouvelles

PharmAthene Reports First Quarter 2017 Financial and Operational Results

PharmAthene Reports Year-End 2016 Financial and Operational Results

PharmAthene Announces Record Date and Meeting Date for Special Meeting of Stockholders Regarding Proposed Merger Transaction ...

PPMH Wholly-Owned Subsidiary, mPath Discovery LLC, Expands Client Base with Multiple New Channel Partnership Agreements

Altimmune to Present at the BIO CEO & Investor Conference

PharmAthene and Altimmune Announce Merger to Create Immunotherapeutics Company Targeting Infectious Diseases

PharmAthene Declares $2.91 Special Cash Dividend on Common Stock

PharmAthene Receives Final Payment from SIGA of $83.9 Million

PharmAthene Reports Third Quarter 2016 Financial and Operational Results

PharmAthene Announces Receipt of Payments from SIGA

PIP - Frequently Asked Questions (FAQ)

PIP Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Pourquoi rejoindre ADVFN?

Tout ce dont les traders professionnels ont besoin.

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE